Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)
- Conditions
- First Posted Date
- 2006-04-03
- Last Posted Date
- 2016-10-03
- Lead Sponsor
- German CLL Study Group
- Target Recruit Count
- 75
- Registration Number
- NCT00309881
- Locations
- 🇩🇪
Kreiskrankenhaus, Bad Hersfeld, Germany
🇩🇪Internistische Onkologische Praxis - Kronach, Kronach, Germany
🇩🇪Universitaetsklinikum Essen, Essen, Germany
Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia
- Conditions
- Interventions
- First Posted Date
- 2006-01-25
- Last Posted Date
- 2018-05-11
- Lead Sponsor
- German CLL Study Group
- Target Recruit Count
- 97
- Registration Number
- NCT00281892
- Locations
- 🇩🇪
Caritas - Krakenhaus Lebach, Lebach, Germany
🇩🇪I. Frauenklinik und Hebammenschule der Ludwig-Maximillians Universitaet Muenchen, Munich, Germany
🇩🇪Praxis fuer Haematologie und Interne Onkologie, Norderstedt, Germany
Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients With Prolymphocytic Leukemia
- Conditions
- First Posted Date
- 2006-01-25
- Last Posted Date
- 2016-09-26
- Lead Sponsor
- German CLL Study Group
- Target Recruit Count
- 21
- Registration Number
- NCT00281931
- Locations
- 🇩🇪
Helios Klinikum Erfurt, Erfurt, Germany
Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia
- Conditions
- Interventions
- Biological: alemtuzumabBiological: anti-thymocyte globulinBiological: filgrastimBiological: rituximabBiological: therapeutic allogeneic lymphocytesDrug: busulfanDrug: cyclophosphamideDrug: cyclosporineDrug: fludarabine phosphateDrug: methotrexateDrug: mycophenolate mofetilProcedure: peripheral blood stem cell transplantationRadiation: radiation therapy
- First Posted Date
- 2006-01-25
- Last Posted Date
- 2017-07-24
- Lead Sponsor
- German CLL Study Group
- Target Recruit Count
- 100
- Registration Number
- NCT00281983
- Locations
- 🇩🇪
Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin, Germany
🇩🇪University Hospital of Leipzig, Leipzig, Germany
🇩🇪Klinikum der Universitaet Regensburg, Regensburg, Germany
Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
- Conditions
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2018-05-11
- Lead Sponsor
- German CLL Study Group
- Target Recruit Count
- 17
- Registration Number
- NCT00278213
- Locations
- 🇦🇹
Allgemeines Krankenhaus - Universitatskliniken, Vienna, Austria
🇦🇹Hanuschkrankenhaus, Vienna, Austria
🇩🇪Allgemeinen Krankenhaus Celle Kinderklinik, Celle, Germany
Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia
- Conditions
- Interventions
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2016-10-03
- Lead Sponsor
- German CLL Study Group
- Target Recruit Count
- 12
- Registration Number
- NCT00278265
- Locations
- 🇩🇪
Praxis fuer Haematologie und Interne Onkologie, Norderstedt, Germany
🇩🇪St. Marien - Krankenhaus Siegen GMBH, Siegen, Germany
🇩🇪Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm, Ulm, Germany
Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic Leukemia
- Conditions
- First Posted Date
- 2006-01-13
- Last Posted Date
- 2016-09-26
- Lead Sponsor
- German CLL Study Group
- Target Recruit Count
- 30
- Registration Number
- NCT00276809
- Locations
- 🇩🇪
Medizinische Hochschule Hannover, Hannover, Germany
🇩🇪Universitatsklinikum Heidelberg, Heidelberg, Germany
🇩🇪University Hospital Schleswig-Holstein - Kiel Campus, Kiel, Germany
Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia
- Conditions
- Interventions
- First Posted Date
- 2006-01-13
- Last Posted Date
- 2019-05-23
- Lead Sponsor
- German CLL Study Group
- Target Recruit Count
- 375
- Registration Number
- NCT00276848
- Locations
- 🇩🇪
St. Marienhospital - Vechta, Vechta, Germany
🇩🇪Evangelisches Krankenhaus Essen Werden, Essen, Germany
🇩🇪Klinikum Frankfurt (Oder) GmbH, Frankfurt, Germany
Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
- Conditions
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2018-05-11
- Lead Sponsor
- German CLL Study Group
- Target Recruit Count
- 60
- Registration Number
- NCT00274963
- Locations
- 🇩🇪
Schwerpunktpraxis fuer Haematologie und Internistische Onkologie, Berlin, Germany
🇩🇪Internistische Gemeinschaftspraxis - Halle, Halle, Germany
🇩🇪Internistische Praxis - Neuss, Neuss, Germany
Alemtuzumab in Treating Patients With Advanced Chronic Lymphocytic Leukemia That Did Not Respond to Previous Fludarabine
- Conditions
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- German CLL Study Group
- Registration Number
- NCT00274976
- Locations
- 🇩🇪
Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie, Ansbach, Germany
🇩🇪Haematolo-Onkologische Schwerpunktpraxis - Berlin, Berlin, Germany
🇩🇪Specialist Practice for Oncology, Aschaffenburg, Germany